Compare ImmunityBio Inc. Common Stock (IBRX) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Sibanye Stillwater Ltd — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Sibanye Stillwater Ltd trades at $10.1 (market cap $6.89B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Sibanye Stillwater Ltd pays a 8.36% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Sibanye Stillwater Ltd for 51 Days on average.
| IBRX | SBSW | |
|---|---|---|
Market Cap | $10.33B | $6.89B |
Volume | 11,745,198 | 5,024,779 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $21.12 |
52-Week Low | $1.98 | $8.00 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $10.79B | $7.79B |
Dividend Yield | — | 8.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sibanye Stillwater (SBSW) trades at $9.91, down 1.0% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company reported a net loss of $5.17 billion in 2025 despite revenue of $129.68 billion, though 2026 projections show a return to profitability. Recent news highlights strong first-half 2026 results, including 54% revenue growth and a 111% surge in EBITDA, signaling a potential operational turnaround.
The outlook is mixed: analyst consensus is a 'Buy' with a $14.25 price target, implying significant upside, but risks include volatile commodity prices, high debt levels, and inconsistent earnings history. The stock offers value with low P/E and P/S ratios, yet investors must weigh the bullish analyst sentiment against underlying financial volatility and macroeconomic pressures on mining sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
